Suzhou, China

Fenghua Meng

This inventor holds 7 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 6 EPO patents. Top assignees: Brightgene Bio-Medical Technology Co., Ltd., Ssens B.v., Brightgene Bio-Medical Technology (Suzhou) Co., Ltd.. Active years: 2015-2020.

USPTO Granted Patents = 7 

% Patents Active = 42.9


 

Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 9(Granted Patents)


Location History:

  • Suzhou, CN (2015 - 2019)
  • Jiangsu, CN (2017 - 2020)

Company Filing History:


Years Active: 2015-2020

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Journey of Fenghua Meng

Introduction: Fenghua Meng, a pioneering inventor hailing from Suzhou, China, has made significant contributions to the world of technology and innovation.

Latest Patents: Fenghua Meng's latest patents focus on advancements in renewable energy technologies, particularly in the field of solar power efficiency and storage solutions.

Career Highlights: With a career spanning over two decades, Fenghua Meng has been at the forefront of cutting-edge research and development in the renewable energy sector. Her work has led to the creation of groundbreaking technologies that have revolutionized the way we harness and utilize solar energy.

Collaborations: Throughout her career, Fenghua Meng has collaborated with leading research institutions, universities, and companies worldwide to further the development of sustainable energy solutions. Her collaborative efforts have resulted in the successful implementation of innovative technologies in real-world applications.

Conclusion: Fenghua Meng's dedication to innovation and sustainability has solidified her reputation as a trailblazer in the field of renewable energy. Her continued commitment to pushing the boundaries of technological advancement serves as an inspiration to aspiring inventors and researchers globally.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…